𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: A phase I study

✍ Scribed by Carla F.M. Moltoff; Helma M. Prinssen; Peter Kenemans; Arjan C. van Hof; Wim den Hollander; René H.M. Verheijen


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
155 KB
Volume
80
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


cure. Recurrent disease often shows an increased resistance to chemotherapeutic agents. Therefore, other treatment modalities, like (radio)immunotherapy using